Brief: BioArctic Says Eisai Projects Leqembi Revenue To Total JPY 56.5 Billion For FY 2024
May 14 (Reuters) - BioArctic AB BIOAb.ST :
* EISAI PROJECTS LEQEMBI® REVENUE TO TOTAL JPY 56.5 BILLION
FOR
FISCAL YEAR 2024 (APRIL 2024 - MARCH 2025)
* BIOARCTIC AB - WOULD GENERATE APPROXIMATELY SEK 360 M IN
NET
ROYALTY TO BIOARCTIC.
* BIOARCTIC -EISAI'S FY2023 (APRIL 2023 THROUGH MARCH 2024),
LEQEMBI SALES REACHED JPY 4.3 BILLION, RESULTING IN SEK 28.2 M
IN NET ROYALTY TO BIOARCTIC
Source text for Eikon: ID:nWkr1R3KjT
Further company coverage: BIOAb.ST
((Reuters.Briefs@thomsonreuters.com;))
Recent news on BioArctic AB
See all newsBrief: BioArctic And Lilly Sign Research, Collaboration Agreement
Brief: Bioarctic AB Declares Dividend Of Sek 2 Per Share With 1 June 2026 Record Date
Brief: Bioarctic Partner Eisai Presents Leqembi Sales Simulation
Sweden's BioArctic Q1 revenue drops sharply despite higher Leqembi royalties
Brief: BioArctic Q1 Operating Profit SEK 210.8 Million